Area of research
Pharmacology · Oncology
Research interest
Research interests include Tamoxifen, Breast cancer, CYP2D6, Genotype, Pharmacogenetics, and Metabolite.
Cross‐Ancestry Genome‐Wide Association Study Defines the Extended <scp><i>CYP2D6</i></scp> Locus as the Principal Genetic Determinant of Endoxifen Plasma Concentrations
Improved Prediction of Endoxifen Metabolism by CYP2D6 Genotype in Breast Cancer Patients Treated with Tamoxifen
The formation of estrogen-like tamoxifen metabolites and their influence on enzyme activity and gene expression of ADME genes
Abstract 5033: Optimized CYP2D6 phenotype assignment for plasma endoxifen prediction in breast cancer patients treated with tamoxifen
Highly sensitive simultaneous quantification of estrogenic tamoxifen metabolites and steroid hormones by LC-MS/MS
CYP2D6 Genotype and Adjuvant Tamoxifen: Meta-Analysis of Heterogeneous Study Populations